Trends in Healthcare Expenditures Among US Adults With Hypertension: National Estimates, 2003–2014

Abstract

BackgroundOne in 3 US adults has high blood pressure, or hypertension. As prior projections suggest hypertension is the costliest of all cardiovascular diseases, it is important to define the current state of healthcare expenditures related to hypertension.Methods and ResultsWe used a nationally representative database, the Medical Expenditure Panel Survey, to calculate the estimated annual healthcare expenditure for patients with hypertension and to measure trends in expenditure longitudinally over a 12‐year period. A 2‐part model was used to estimate adjusted incremental expenditures for individuals with hypertension versus those without hypertension. Sex, race/ethnicity, education, insurance status, census region, income, marital status, Charlson Comorbidity Index, and year category were included as covariates. The 2003–2014 pooled data include a total sample of 224 920 adults, of whom 36.9% had hypertension. Unadjusted mean annual medical expenditure attributable to patients with hypertension was $9089. Relative to individuals without hypertension, individuals with hypertension had $1920 higher annual adjusted incremental expenditure, 2.5 times the inpatient cost, almost double the outpatient cost, and nearly triple the prescription medication expenditure. Based on the prevalence of hypertension in the United States, the estimated adjusted annual incremental cost is $131 billion per year higher for the hypertensive adult population compared with the nonhypertensive population.ConclusionsIndividuals with hypertension are estimated to face nearly $2000 higher annual healthcare expenditure compared with their nonhypertensive peers. This trend has been relatively stable over 12 years. Healthcare costs associated with hypertension account for about $131 billion. This warrants intense effort toward hypertension prevention and management.

An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study

“…The significant increase in mortality is alarming considering the population size of the 55 and older age group is estimated to increase over the next 30 years (Fig 3C). An increasing mortality rate, with an accelerating rate of change, coupled with an increasing population size for this group may have severe economic and healthcare ramifications in the United States that far exceed current healthcare resource and expenditure estimates [25].…”

Health Status of Female and Male Gulf War and Gulf Era Veterans: A Population-Based Study

“…Apart from hypertension, which is a common chronic condition in the U.S. adult population (Kirkland et al, 2018), the most prevalent medical conditions in women (deployed and nondeployed) are those that share similar symptoms with Gulf War illness (also known as chronic multisymptom illness), including joint pain and stiffness, gastrointestinal upset, * Self-reported, missing data (n ¼ 330).…”

Impact of type 2 diabetes mellitus and physical activity on medication costs in older adults

“…A study that analysed national data on the distribution of drugs in Portugal showed increased costs of medication, from €100 million to €278 million over a 6‐year period . Another study conducted in the USA reported that the annual cost of arterial hypertension medication was US$ 2371, a much higher value compared with normotensive patients, US$ 814 . High drug values may be further justified by the high prevalence of arterial hypertension, which is twice as frequent in patients with type 2 diabetes mellitus.…”